Islamabad, The Board of Directors of Hoechst Pakistan Limited, in a meeting held on June 11, 2024, has approved the finalization of commercial and legal terms for the acquisition of certain products along with associated trademarks from Sanofi affiliates.

According to information available from the Pakistan Stock Exchange (PSX), the proposed transaction is contingent upon obtaining the necessary regulatory approvals and completing the required legal and transaction documents. The acquisition aims to enhance the long-term value for shareholders, building on the current licensing arrangements with Sanofi.

The post Hoechst Pakistan Limited to Acquire Products and Trademarks from Sanofi appeared first on AsiaNet-Pakistan.